论文部分内容阅读
目的观察疏血通联合奥扎格雷钠治疗进展性缺血性脑卒中的疗效。方法对确诊为进展性缺血性脑卒中患者随机分为疏血通联合奥扎格雷钠治疗组及常规对照组,经治疗14 d后分别进行治疗前后及两组间的神经功能缺损情况和临床疗效比较。结果两组治疗后的神经功能缺损程度较治疗前轻(P<0.05),治疗后疏血通联合奥扎格雷钠治疗组神经功能缺损程度明显较对照组轻(P<0.05)。结论疏血通联合奥扎格雷钠治疗进展性缺血性脑卒中效果较对照组好,疗效可靠。
Objective To observe the curative effect of Shuxuetong combined with ozagrel sodium on patients with progressive ischemic stroke. Methods The patients diagnosed as progressive ischemic stroke were randomly divided into Shuxuetong combined with ozagrel sodium treatment group and conventional control group, after 14 days of treatment, respectively, before and after treatment and between the two groups of neurological deficit and clinical Comparison of efficacy. Results The neurological deficits after treatment in both groups were significantly lower than those before treatment (P <0.05). After the treatment, the neurological deficits of Shuxuetong combined with ozagrel sodium group were significantly lower than those of the control group (P <0.05). Conclusion Shuxuetong combined with ozagrel sodium in treatment of progressive ischemic stroke better than the control group, the curative effect is reliable.